{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:15:58Z","timestamp":1790691358637,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2023,1,5]]},"DOI":"10.1038\/s41388-022-02542-0","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T10:04:14Z","timestamp":1668679454000},"page":"138-153","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Hypoxia-induced circADAMTS6 in a TDP43-dependent manner accelerates glioblastoma progression via ANXA2\/ NF-\u03baB pathway"],"prefix":"10.1038","volume":"42","author":[{"given":"Shulin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouji","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qindong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5821-7550","authenticated-orcid":false,"given":"Yanhua","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7241-6994","authenticated-orcid":false,"given":"Jianye","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7759-1687","authenticated-orcid":false,"given":"Shaobo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingtong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7478-8898","authenticated-orcid":false,"given":"Hao","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7787-9330","authenticated-orcid":false,"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,17]]},"reference":[{"key":"2542_CR1","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1093\/neuonc\/noab200","volume":"23","author":"QT Ostrom","year":"2021","unstructured":"Ostrom QT, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014-2018. Neuro Oncol. 2021;23:iii1\u2013iii105. https:\/\/doi.org\/10.1093\/neuonc\/noab200","journal-title":"Neuro Oncol"},{"key":"2542_CR2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 2021;23:1231\u201351. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"2542_CR3","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1001\/jama.2015.16669","volume":"314","author":"R Stupp","year":"2015","unstructured":"Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA, et al. Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial. JAMA. 2015;314:2535\u201343. https:\/\/doi.org\/10.1001\/jama.2015.16669","journal-title":"JAMA"},{"key":"2542_CR4","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/S1470-2045(14)70379-1","volume":"15","author":"R Stupp","year":"2014","unstructured":"Stupp R, Hegi ME, Gorlia T, Erridge SC, Perry J, Hong YK, et al. Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2014;15:1100\u20138. https:\/\/doi.org\/10.1016\/S1470-2045(14)70379-1","journal-title":"Lancet Oncol"},{"key":"2542_CR5","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1056\/NEJMoa1707358","volume":"377","author":"W Wick","year":"2017","unstructured":"Wick W, Gorlia T, Bendszus M, Taphoorn M, Sahm F, Harting I, et al. Lomustine and bevacizumab in progressive glioblastoma. N. Engl J Med. 2017;377:1954\u201363. https:\/\/doi.org\/10.1056\/NEJMoa1707358","journal-title":"N. Engl J Med"},{"key":"2542_CR6","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1200\/JCO.2005.04.5302","volume":"24","author":"DA Reardon","year":"2006","unstructured":"Reardon DA, Rich JN, Friedman HS, Bigner DD. Recent advances in the treatment of malignant astrocytoma. J Clin Oncol. 2006;24:1253\u201365. https:\/\/doi.org\/10.1200\/JCO.2005.04.5302","journal-title":"J Clin Oncol"},{"key":"2542_CR7","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","volume":"20","author":"LS Kristensen","year":"2019","unstructured":"Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20:675\u201391. https:\/\/doi.org\/10.1038\/s41576-019-0158-7","journal-title":"Nat Rev Genet"},{"key":"2542_CR8","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41556-021-00639-4","volume":"23","author":"X Gao","year":"2021","unstructured":"Gao X, Xia X, Li F, Zhang M, Zhou H, Wu X, et al. Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR-STAT3 signalling. Nat Cell Biol. 2021;23:278\u201391. https:\/\/doi.org\/10.1038\/s41556-021-00639-4","journal-title":"Nat Cell Biol"},{"key":"2542_CR9","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1093\/neuonc\/noaa279","volume":"23","author":"Y Liu","year":"2021","unstructured":"Liu Y, Li Z, Zhang M, Zhou H, Wu X, Zhong J, et al. Rolling-translated EGFR variants sustain EGFR signaling and promote glioblastoma tumorigenicity. Neuro Oncol. 2021;23:743\u201356. https:\/\/doi.org\/10.1093\/neuonc\/noaa279","journal-title":"Neuro Oncol."},{"key":"2542_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01253-y","volume":"19","author":"J Lou","year":"2020","unstructured":"Lou J, Hao Y, Lin K, Lyu Y, Chen M, Wang H, et al. Circular RNA CDR1as disrupts the p53\/MDM2 complex to inhibit gliomagenesis. Mol Cancer. 2020;19:138 https:\/\/doi.org\/10.1186\/s12943-020-01253-y","journal-title":"Mol Cancer"},{"key":"2542_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.semcancer.2017.07.004","volume":"52","author":"IN Khan","year":"2018","unstructured":"Khan IN, Ullah N, Hussein D, Saini KS. Current and emerging biomarkers in tumors of the central nervous system: possible diagnostic, prognostic and therapeutic applications. Semin Cancer Biol. 2018;52:85\u2013102. https:\/\/doi.org\/10.1016\/j.semcancer.2017.07.004","journal-title":"Semin Cancer Biol"},{"key":"2542_CR12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41580-020-0243-y","volume":"21","author":"LL Chen","year":"2020","unstructured":"Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 2020;21:475\u201390. https:\/\/doi.org\/10.1038\/s41580-020-0243-y","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2542_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-021-00486-7","volume":"6","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Qian J, Gu C, Yang Y. Alternative splicing and cancer: a systematic review. Signal Transduct Target Ther. 2021;6:78 https:\/\/doi.org\/10.1038\/s41392-021-00486-7","journal-title":"Signal Transduct Target Ther"},{"key":"2542_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-019-0629-7","volume":"11","author":"S Li","year":"2019","unstructured":"Li S, Han L. Circular RNAs as promising biomarkers in cancer: detection, function, and beyond. Genome Med. 2019;11:15 https:\/\/doi.org\/10.1186\/s13073-019-0629-7","journal-title":"Genome Med"},{"key":"2542_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0934-6","volume":"18","author":"Q Shang","year":"2019","unstructured":"Shang Q, Yang Z, Jia R, Ge S. The novel roles of circRNAs in human cancer. Mol Cancer. 2019;18:6 https:\/\/doi.org\/10.1186\/s12943-018-0934-6","journal-title":"Mol Cancer"},{"key":"2542_CR16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41568-020-00306-0","volume":"21","author":"GJ Goodall","year":"2021","unstructured":"Goodall GJ, Wickramasinghe VO. RNA in cancer. Nat Rev Cancer. 2021;21:22\u201336. https:\/\/doi.org\/10.1038\/s41568-020-00306-0","journal-title":"Nat Rev Cancer"},{"key":"2542_CR17","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/neuonc\/noaa214","volume":"23","author":"Y Wei","year":"2021","unstructured":"Wei Y, Lu C, Zhou P, Zhao L, Lyu X, Yin J, et al. EIF4A3-induced circular RNA ASAP1 promotes tumorigenesis and temozolomide resistance of glioblastoma via NRAS\/MEK1\/ERK1-2 signaling. Neuro Oncol. 2021;23:611\u201324. https:\/\/doi.org\/10.1093\/neuonc\/noaa214","journal-title":"Neuro Oncol"},{"key":"2542_CR18","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1093\/neuonc\/noz128","volume":"21","author":"S Zhang","year":"2019","unstructured":"Zhang S, Liao K, Miao Z, Wang Q, Miao Y, Guo Z, et al. CircFOXO3 promotes glioblastoma progression by acting as a competing endogenous RNA for NFAT5. Neuro Oncol. 2019;21:1284\u201396. https:\/\/doi.org\/10.1093\/neuonc\/noz128","journal-title":"Neuro Oncol."},{"key":"2542_CR19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.canlet.2020.07.040","volume":"495","author":"D Chen","year":"2020","unstructured":"Chen D, Chou FJ, Chen Y, Tian H, Wang Y, You B, et al. Targeting the radiation-induced TR4 nuclear receptor-mediated QKI\/circZEB1\/miR-141-3p\/ZEB1 signaling increases prostate cancer radiosensitivity. Cancer Lett. 2020;495:100\u201311. https:\/\/doi.org\/10.1016\/j.canlet.2020.07.040","journal-title":"Cancer Lett"},{"key":"2542_CR20","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1136\/annrheumdis-2021-219969","volume":"80","author":"S Shen","year":"2021","unstructured":"Shen S, Yang Y, Shen P, Ma J, Fang B, Wang Q, et al. circPDE4B prevents articular cartilage degeneration and promotes repair by acting as a scaffold for RIC8A and MID1. Ann Rheum Dis. 2021;80:1209\u201319. https:\/\/doi.org\/10.1136\/annrheumdis-2021-219969","journal-title":"Ann Rheum Dis"},{"key":"2542_CR21","doi-asserted-by":"publisher","first-page":"12849","DOI":"10.1021\/acsnano.7b08225","volume":"11","author":"J Chen","year":"2017","unstructured":"Chen J, Luo H, Liu Y, Zhang W, Li H, Luo T, et al. Oxygen-self-produced nanoplatform for relieving hypoxia and breaking resistance to sonodynamic treatment of pancreatic cancer. ACS Nano. 2017;11:12849\u201362. https:\/\/doi.org\/10.1021\/acsnano.7b08225.","journal-title":"ACS Nano"},{"key":"2542_CR22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.stem.2017.10.005","volume":"22","author":"J Man","year":"2018","unstructured":"Man J, Yu X, Huang H, Zhou W, Xiang C, Huang H, et al. Hypoxic induction of vasorin regulates notch1 turnover to maintain glioma stem-like cells. Cell Stem Cell. 2018;22:104\u2013.e6. https:\/\/doi.org\/10.1016\/j.stem.2017.10.005","journal-title":"Cell Stem Cell"},{"key":"2542_CR23","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1158\/1078-0432.CCR-14-0618","volume":"21","author":"CH Hsieh","year":"2015","unstructured":"Hsieh CH, Lin YJ, Wu CP, Lee HT, Shyu WC, Wang CC. Livin contributes to tumor hypoxia-induced resistance to cytotoxic therapies in glioblastoma multiforme. Clin Cancer Res. 2015;21:460\u201370. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-0618","journal-title":"Clin Cancer Res"},{"key":"2542_CR24","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.trecan.2015.10.009","volume":"1","author":"D Hambardzumyan","year":"2015","unstructured":"Hambardzumyan D, Bergers G. Glioblastoma: defining tumor niches. Trends Cancer. 2015;1:252\u201365. https:\/\/doi.org\/10.1016\/j.trecan.2015.10.009","journal-title":"Trends Cancer"},{"key":"2542_CR25","doi-asserted-by":"publisher","first-page":"D87","DOI":"10.1093\/nar\/gkz1001","volume":"48","author":"O Fornes","year":"2020","unstructured":"Fornes O, Castro-Mondragon JA, Khan A, van der Lee R, Zhang X, Richmond PA, et al. JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2020;48:D87\u2013D92. https:\/\/doi.org\/10.1093\/nar\/gkz1001","journal-title":"Nucleic Acids Res"},{"key":"2542_CR26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/15476286.2015.1128065","volume":"13","author":"DB Dudekula","year":"2016","unstructured":"Dudekula DB, Panda AC, Grammatikakis I, De S, Abdelmohsen K, Gorospe M. CircInteractome: a web tool for exploring circular RNAs and their interacting proteins and microRNAs. RNA Biol. 2016;13:34\u201342. https:\/\/doi.org\/10.1080\/15476286.2015.1128065","journal-title":"RNA Biol"},{"key":"2542_CR27","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1016\/j.ymthe.2021.06.023","volume":"29","author":"W Qiu","year":"2021","unstructured":"Qiu W, Guo X, Li B, Wang J, Qi Y, Chen Z, et al. Exosomal miR-1246 from glioma patient body fluids drives the differentiation and activation of myeloid-derived suppressor cells. Mol Ther. 2021;29:3449\u201364. https:\/\/doi.org\/10.1016\/j.ymthe.2021.06.023","journal-title":"Mol Ther"},{"key":"2542_CR28","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrg.2016.20","volume":"17","author":"DW Thomson","year":"2016","unstructured":"Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17:272\u201383. https:\/\/doi.org\/10.1038\/nrg.2016.20","journal-title":"Nat Rev Genet"},{"key":"2542_CR29","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/ncb2611","volume":"14","author":"D Gibbings","year":"2012","unstructured":"Gibbings D, Mostowy S, Jay F, Schwab Y, Cossart P, Voinnet O. Selective autophagy degrades DICER and AGO2 and regulates miRNA activity. Nat Cell Biol. 2012;14:1314\u201321. https:\/\/doi.org\/10.1038\/ncb2611","journal-title":"Nat Cell Biol"},{"key":"2542_CR30","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.cell.2018.02.051","volume":"173","author":"J Sheu-Gruttadauria","year":"2018","unstructured":"Sheu-Gruttadauria J, MacRae IJ. Phase transitions in the assembly and function of human miRISC. Cell. 2018;173:946\u2013.e16. https:\/\/doi.org\/10.1016\/j.cell.2018.02.051","journal-title":"Cell"},{"key":"2542_CR31","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.molp.2015.12.021","volume":"9","author":"G Sablok","year":"2016","unstructured":"Sablok G, Zhao H, Sun X. Plant circular RNAs (circRNAs): transcriptional regulation beyond miRNAs in plants. Mol Plant. 2016;9:192\u20134. https:\/\/doi.org\/10.1016\/j.molp.2015.12.021","journal-title":"Mol Plant"},{"key":"2542_CR32","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1161\/CIRCULATIONAHA.118.038361","volume":"139","author":"S Huang","year":"2019","unstructured":"Huang S, Li X, Zheng H, Si X, Li B, Wei G, et al. Loss of super-enhancer-regulated circRNA Nfix induces cardiac regeneration after myocardial infarction in adult mice. Circulation. 2019;139:2857\u201376. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.038361","journal-title":"Circulation"},{"key":"2542_CR33","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s13238-020-00799-3","volume":"12","author":"G Wen","year":"2021","unstructured":"Wen G, Zhou T, Gu W. The potential of using blood circular RNA as liquid biopsy biomarker for human diseases. Protein Cell. 2021;12:911\u201346. https:\/\/doi.org\/10.1007\/s13238-020-00799-3","journal-title":"Protein Cell"},{"key":"2542_CR34","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/hep.31846","volume":"74","author":"Y Niu","year":"2021","unstructured":"Niu Y, Lin Z, Wan A, Sun L, Yan S, Liang H, et al. Loss-of-function genetic screening identifies aldolase A as an essential driver for liver cancer cell growth under hypoxia. Hepatology. 2021;74:1461\u201379. https:\/\/doi.org\/10.1002\/hep.31846","journal-title":"Hepatology"},{"key":"2542_CR35","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.immuni.2020.05.001","volume":"52","author":"J Ni","year":"2020","unstructured":"Ni J, Wang X, Stojanovic A, Zhang Q, Wincher M, B\u00fchler L, et al. Single-cell RNA sequencing of tumor-infiltrating NK cells reveals that inhibition of transcription factor HIF-1\u03b1 Unleashes NK Cell Activity. Immunity. 2020;52:1075\u2013.e8. https:\/\/doi.org\/10.1016\/j.immuni.2020.05.001","journal-title":"Immunity"},{"key":"2542_CR36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41392-020-0152-8","volume":"5","author":"L Li","year":"2020","unstructured":"Li L, Yang L, Fan Z, Xue W, Shen Z, Yuan Y, et al. Hypoxia-induced GBE1 expression promotes tumor progression through metabolic reprogramming in lung adenocarcinoma. Signal Transduct Target Ther. 2020;5:54 https:\/\/doi.org\/10.1038\/s41392-020-0152-8","journal-title":"Signal Transduct Target Ther"},{"key":"2542_CR37","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jhep.2014.08.025","volume":"61","author":"GK Wilson","year":"2014","unstructured":"Wilson GK, Tennant DA, McKeating JA. Hypoxia inducible factors in liver disease and hepatocellular carcinoma: current understanding and future directions. J Hepatol. 2014;61:1397\u2013406. https:\/\/doi.org\/10.1016\/j.jhep.2014.08.025","journal-title":"J Hepatol"},{"key":"2542_CR38","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1093\/nar\/gkaa005","volume":"48","author":"P Zhang","year":"2020","unstructured":"Zhang P, Zhang XO, Jiang T, Cai L, Huang X, Liu Q, et al. Comprehensive identification of alternative back-splicing in human tissue transcriptomes. Nucleic Acids Res. 2020;48:1779\u201389. https:\/\/doi.org\/10.1093\/nar\/gkaa005","journal-title":"Nucleic Acids Res"},{"key":"2542_CR39","doi-asserted-by":"publisher","unstructured":"Qing G, Lu Q, Xiong Y, Zhang L, Wang H, Li X, et al. New opportunities and challenges of smart polymers in post-translational modification proteomics. Adv Mater. 2017;29. https:\/\/doi.org\/10.1002\/adma.201604670.","DOI":"10.1002\/adma.201604670"},{"key":"2542_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2016.06.020","volume":"45","author":"J Liu","year":"2016","unstructured":"Liu J, Qian C, Cao X. Post-translational modification control of innate immunity. Immunity. 2016;45:15\u201330. https:\/\/doi.org\/10.1016\/j.immuni.2016.06.020","journal-title":"Immunity"},{"key":"2542_CR41","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nrm3143","volume":"12","author":"D Vucic","year":"2011","unstructured":"Vucic D, Dixit VM, Wertz IE. Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death. Nat Rev Mol Cell Biol. 2011;12:439\u201352. https:\/\/doi.org\/10.1038\/nrm3143","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2542_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.canlet.2018.07.036","volume":"435","author":"WS Wei","year":"2018","unstructured":"Wei WS, Chen X, Guo LY, Li XD, Deng MH, Yuan GJ, et al. TRIM65 supports bladder urothelial carcinoma cell aggressiveness by promoting ANXA2 ubiquitination and degradation. Cancer Lett. 2018;435:10\u201322. https:\/\/doi.org\/10.1016\/j.canlet.2018.07.036","journal-title":"Cancer Lett"},{"key":"2542_CR43","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.gpb.2011.12.001","volume":"10","author":"S Deng","year":"2012","unstructured":"Deng S, Jing B, Xing T, Hou L, Yang Z. Overexpression of annexin A2 is associated with abnormal ubiquitination in breast cancer. Genomics Proteom Bioinform. 2012;10:153\u20137. https:\/\/doi.org\/10.1016\/j.gpb.2011.12.001","journal-title":"Genomics Proteom Bioinform"},{"key":"2542_CR44","doi-asserted-by":"publisher","first-page":"6907","DOI":"10.1111\/jcmm.14574","volume":"23","author":"Y Tu","year":"2019","unstructured":"Tu Y, Xie P, Du X, Fan L, Bao Z, Sun G, et al. S100A11 functions as novel oncogene in glioblastoma via S100A11\/ANXA2\/NF-\u03baB positive feedback loop. J Cell Mol Med. 2019;23:6907\u201318. https:\/\/doi.org\/10.1111\/jcmm.14574","journal-title":"J Cell Mol Med"},{"key":"2542_CR45","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s13238-018-0513-z","volume":"9","author":"YS Wang","year":"2018","unstructured":"Wang YS, Li H, Li Y, Zhu H, Jin YH. Identification of natural compounds targeting Annexin A2 with an anti-cancer effect. Protein Cell. 2018;9:568\u201379. https:\/\/doi.org\/10.1007\/s13238-018-0513-z","journal-title":"Protein Cell"},{"key":"2542_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-015-0428-8","volume":"14","author":"M Kpetemey","year":"2015","unstructured":"Kpetemey M, Dasgupta S, Rajendiran S, Das S, Gibbs LD, Shetty P, et al. MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression. Mol Cancer. 2015;14:156 https:\/\/doi.org\/10.1186\/s12943-015-0428-8","journal-title":"Mol Cancer"},{"key":"2542_CR47","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1053\/j.gastro.2010.08.054","volume":"140","author":"S Sarkar","year":"2011","unstructured":"Sarkar S, Swiercz R, Kantara C, Hajjar KA, Singh P. Annexin A2 mediates up-regulation of NF-\u03baB, \u03b2-catenin, and stem cell in response to progastrin in mice and HEK-293 cells. Gastroenterology. 2011;140:583\u2013.e4. https:\/\/doi.org\/10.1053\/j.gastro.2010.08.054","journal-title":"Gastroenterology"},{"key":"2542_CR48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13046-017-0581-6","volume":"36","author":"Y Wang","year":"2017","unstructured":"Wang Y, Chen K, Cai Y, Cai Y, Yuan X, Wang L, et al. Annexin A2 could enhance multidrug resistance by regulating NF-\u03baB signaling pathway in pediatric neuroblastoma. J Exp Clin Cancer Res. 2017;36:111 https:\/\/doi.org\/10.1186\/s13046-017-0581-6","journal-title":"J Exp Clin Cancer Res"},{"key":"2542_CR49","doi-asserted-by":"publisher","first-page":"e2022779118","DOI":"10.1073\/pnas.2022779118","volume":"118","author":"R Liu","year":"2021","unstructured":"Liu R, Tan J, Shen X, Jiang K, Wang C, Zhu G, et al. Therapeutic targeting of FOS in mutant TERT cancers through removing TERT suppression of apoptosis via regulating survivin and TRAIL-R2. Proc Natl Acad Sci USA. 2021;118:e2022779118 https:\/\/doi.org\/10.1073\/pnas.2022779118","journal-title":"Proc Natl Acad Sci USA"},{"key":"2542_CR50","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/cas.12914","volume":"107","author":"D Kamide","year":"2016","unstructured":"Kamide D, Yamashita T, Araki K, Tomifuji M, Tanaka Y, Tanaka S, et al. Selective activator protein-1 inhibitor T-5224 prevents lymph node metastasis in an oral cancer model. Cancer Sci. 2016;107:666\u201373. https:\/\/doi.org\/10.1111\/cas.12914","journal-title":"Cancer Sci"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02542-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02542-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02542-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T04:11:15Z","timestamp":1673237475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02542-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,17]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,1,5]]}},"alternative-id":["2542"],"URL":"https:\/\/doi.org\/10.1038\/s41388-022-02542-0","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,17]]},"assertion":[{"value":"3 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}